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OBJECTIVE: To establish the risk factors for joint infection by oxacillin-resistant Staphylococcus aureus (MRSA)
using clinical and epidemiological data.
METHODS: All septic arthritis cases of the knee and hip diagnosed and treated in our institution from 2006 to
2012 were evaluated retrospectively. Only patients with cultures identified as microbial agents were included in
the study. The clinical and epidemiological characteristics of the patients were analyzed, seeking the
differences between populations affected by MRSA and oxacillin-sensitive Staphylococcus aureus (MSSA).
RESULTS: S. aureus was isolated in thirty-five patients (46.0%) in our total sample, 25 in the knee and 10 in the
hip. Of these 35 patients, 22 presented with MSSA and 13 presented with MRSA. Provenance from a health
service-related environment, as described by the Centers for Disease Control and Prevention, was the only
variable associated with oxacillin-resistant strains of this bacterium (p=0.001).
CONCLUSION: Provenance from a health service-related environment was associated with a higher incidence of
MRSA-related septic arthritis, suggesting that this agent should be considered in the initial choice of antibiotic
treatment. Previous surgeries of the knee or affected limb and the absence of leukocytes might also be related
to infection with this agent.
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Septic arthritis is an orthopedic disease that is difficult to
characterize epidemiologically (1,2). In adults, the lower
limbs are more often affected, with the knees being the site
of highest incidence, followed by the hips (3-5). In recent
years, the prevalence of this infection has increased due to
the greater number of invasive orthopedic procedures, the
aging population and the increased use of immunosup-
pressant drugs (6,7).
The most common microbial agent in septic arthritis is
Staphylococcus aureus, with a prevalence of approximately
50% (8,9). This bacterium is the most commonly found in all
age groups, with the exception of children younger than two
years of age. Over the last few years, particularly since 2000,
there has been an increasing incidence of oxacillin-resistant
strains of this bacterium (MRSA) (8-11).
Infections by MRSA are increasing, particularly among the
elderly, intravenous drug users and patients who have
undergone orthopedic procedures. This increase has become
a public health care issue in many parts of the world (6,12-14).
According to previously conducted studies, MRSA infec-
tions cause more suppurative complications, prolonged
fevers and longer hospitalizations (15,16).
This situation may be related to a failure to consider the
causative agent in the initial empirical antibiotic therapy.
Weston et al. showed that a delay in starting treatment,
which can occur in cases in which the agent is not
considered in the initial antibiotic therapy, led to a worse
prognosis for the disease (17).
The objective of this research was to establish the risk
factors for joint infections due to MRSA, through a study of
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clinical and epidemiological data. The results of this
research could lead to the consideration of this etiological
agent in the first line of empirical antibiotic therapy for
affected patients.
& METHODS
All of the cases of septic arthritis of the knee and hip
diagnosed and treated in our institution from 2006 to 2012
were evaluated retrospectively. All of the records of patients
with IDC-10 diagnoses of septic arthritis were located and
the epidemiological, clinical and laboratory data were
collected through a detailed chart review, with the
information recorded on a standard form. Patients diag-
nosed with infections for less than a year following a
surgical procedure on the affected limb were excluded
because these cases were considered to be possible infec-
tions of the surgical site. Patients with infections associated
with joint prostheses were also excluded.
Only patients with a culture identifying a microbial agent
in the initial diagnostic puncture or from surgical drainage
were included. All of the cultures were obtained in
appropriate surgical environments using rigorous aseptic
techniques and the materials were deposited in thioglycate
tubes. All of the analyses and procedures were performed
according to the standards established by the Clinical and
Laboratory Standards Institute (CLSI) (18). Among the
selected patients, those with a positive culture for S. aureus
were divided into two groups: strains sensitive to oxacillin
(MSSA) and strains resistant to this antibiotic (MRSA).
The following parameters were analyzed for all of the
patients: sex; age; cause of infection; the provenance of the
patient to categorize the infection as community- or health
services-related, as described by the guidelines of the
Centers for Disease Control and Prevention (19); leukocyte
count, C-reactive protein (CRP) and erithrocytes sedimenta-
tion rate (ESR) values from the initial blood analysis; the
presence of clinical signs, such as fever, pain, or swelling in
the knee or hip; the number of surgical drainages
performed; clinical comorbidities (high blood pressures
and diabetes); prior orthopedic surgeries of the limb or
joint affected; immunosuppression (HIV, inflammatory
arthritis, cancer); the time from onset of symptoms to
drainage; previous joint pain; systemic and articular
complications; and hospitalization time. Gram staining
and synovial fluid culture results were also analyzed.
Univariate statistical analysis was performed using the
chi-square or Fisher’s exact test, or likelihood ratio tests
when the frequency of the event was very low.
The tests were conducted with a level of significance of
5%.
The study was conducted following approval from the
science and research ethics committee of our institution.
& RESULTS
Between 2006 and 2012, 76 cases of septic knee and hip
arthritis were drained and presented positive cultures. S.
aureus was isolated in 35 (46.0%) of these patients, in the
knee in 25 cases and in the hip in the remaining 10 cases.
Twenty-two of these patients presented with MSSA and
13 presented with MRSA. The average age of the patients
with MRSA was 40.5+/-24.9 years old (ranging from 3 to 74
years) and the average age of those with MSSA was 39.2+/
-20.9 years old (ranging from 7 to 76 years).
All of the studied data are summarized in Table 1.
Following univariate statistical analysis, provenance of
the patient from a health service-related environment was
the only variable associated with the presence of oxacillin-
resistant bacterial strains (p= 0.001). Both prior surgery of
the limb or joint affected and the absence of a change in the
leukocyte count suggested a higher frequency of MRSA
isolation but without statistical significance (Table 2).
& DISCUSSION
Septic arthritis is an infection that has a significant impact
on our environment. Our case series presented an average
of approximately 11 cases per year, with approximately 5
cases in which S. aureus was identified among the cultures.
Eder et al., in a 17-year analysis from Israel, found only 110
confirmed cases, while in Switzerland, Clerc et al. encoun-
tered 83 cases in 10 years, considering only knees and hips
(20,21).
S. aureus is the most common agent identified in cases
worldwide, with higher prevalence rates reported in
Europe, Asia, the Middle East, Africa, the United States
and South America (14,21-26). Some studies, such as those
conducted by Frazee et al. in the United States and by
Yamagishi in Japan (14,27), have shown a higher proportion
of MRSA relative to MSSA. In our case series, MSSA strains
remained the majority.
In cases of MRSA, patients might not receive appropriate
initial empirical antibiotic treatment because the resistance
profile can only be identified from the results of cultures
collected from the initial puncture or from surgical
drainage. Thus, it is critical to attempt to identify risk
factors for the presence of MRSA, with the aim of
improving the efficacy of the initial antibiotic therapy. In
their series, Yamagishi et al., Clerc et al., and Helito et al.
found it necessary to broaden the antibiotic therapy
spectrum after analyzing definitive cultures with an
antibiogram (20,25,27).
Among the variables analyzed in this study, the only one
with a confirmed statistical correlation for the presence of
MRSA was the provenance of the patient. Patients with a
close relationship with health care services, according to the
definition of the Centers for Disease Control and Prevention
(19), had a greater likelihood of presenting cultures positive
for MRSA. The higher prevalence of infections in hospital
services and in asymptomatic carriers of this bacterium has
been described previously (14,21).
Among the variables that suggested a relationship with
MRSA, we believe that surgery performed previously on the
limb or affected joint might have high significance.
Causative agents of musculoskeletal infections are often
present in an inactive state, manifesting themselves later.
Courvoisier et al. described two cases of osteomyelitis of the
tibia that manifested twenty years after a surgical procedure
of the leg (28). These situations could warrant special
attention and broadening of the spectrum of antibiotics used
for the initial presentation.
Unlike the situation with limb surgeries, we did not find a
plausible explanation for the absence of leukocytes in cases
affected by MRSA. According to the studies of Arnold et al.
and Martinez-Aguilar et al., MRSA infections evolve with
more fevers and suppurative complications, conditions that
are usually associated with an increased leukocyte count;
however, this was not the finding in our case series (15,16).
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Further studies with more patients must be conducted to
confirm this result.
None of the other variables studied reflected a difference
between the MRSA and MSSA groups, not even the
presence and number of comorbidities or immunosuppres-
sion; therefore, distinguishing this profile of sensitivity in
the initial presentation remains difficult.
This study had some limitations, such as the retrospective
data analysis and the relatively small number of patients.
However, given the lack of literature data on this subject in
our country, we believe that this analysis could be very
relevant.
Provenance from a health services-related environment
was associated with a higher incidence of septic arthritis
related to MRSA, suggesting that this agent should be
considered in the initial selection of an antibiotic treatment.
Prior surgeries to the affected joint or limb and the absence
of leukocytes might also be related to articular infections
caused by this agent.
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